Program in Biochemistry and Structural Biology, Cell and Developmental Biology, and Molecular Biology, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, United States.
Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States.
Elife. 2018 Nov 28;7:e39658. doi: 10.7554/eLife.39658.
Pericentromeric satellite repeats are enriched in 5-methylcytosine (5mC). Loss of 5mC at these sequences is common in cancer and is a hallmark of Immunodeficiency, Centromere and Facial abnormalities (ICF) syndrome. While the general importance of 5mC is well-established, the specific functions of 5mC at pericentromeres are less clear. To address this deficiency, we generated a viable animal model of pericentromeric hypomethylation through mutation of the ICF-gene . Deletion of zebrafish caused a progressive loss of 5mC at pericentromeres and ICF-like phenotypes. Hypomethylation of these repeats triggered derepression of pericentromeric transcripts and activation of an interferon-based innate immune response. Injection of pericentromeric RNA is sufficient to elicit this response in wild-type embryos, and mutation of the MDA5-MAVS dsRNA-sensing machinery blocks the response in mutants. These findings identify activation of the innate immune system as an early consequence of pericentromeric hypomethylation, implicating derepression of pericentromeric transcripts as a trigger of autoimmunity.
This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).
着丝粒卫星重复序列富含 5-甲基胞嘧啶(5mC)。这些序列中 5mC 的丢失在癌症中很常见,是免疫缺陷、着丝粒和面部异常(ICF)综合征的标志。虽然 5mC 的一般重要性已得到充分确立,但 5mC 在着丝粒处的具体功能尚不清楚。为了解决这一不足,我们通过 ICF 基因的突变生成了可行的着丝粒低甲基化动物模型。斑马鱼 的缺失导致着丝粒处的 5mC 逐渐丢失和 ICF 样表型。这些重复序列的低甲基化触发了着丝粒转录本的去抑制和基于干扰素的先天免疫反应的激活。将着丝粒 RNA 注射到野生型胚胎中足以引发这种反应,而 MDA5-MAVS dsRNA 感应机制的突变可阻止突变体中的反应。这些发现将先天免疫系统的激活确定为着丝粒低甲基化的早期后果,表明着丝粒转录本的去抑制是自身免疫的触发因素。
本文经过编辑过程,作者决定如何应对同行评审中提出的问题。审稿人的评估是所有问题都已得到解决(见评审意见信)。